Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Melanoma 38Carcinoma, Renal Cell 12Carcinoma, Non-Small-Cell Lung 12Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 8Carcinoma, Merkel Cell 8Uterine Cervical Neoplasms 7Stomach Neoplasms 7Colorectal Neoplasms 6Carcinoma, Transitional Cell 6Carcinoma, Hepatocellular 6Small Cell Lung Carcinoma 5Neoplasms 5Kidney Neoplasms 5Urinary Bladder Neoplasms 4Triple Negative Breast Neoplasms 4Esophageal Neoplasms 3Breast Neoplasms 3Urogenital Neoplasms 2Skin Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Neoplasms by Histologic Type 2Microsatellite Instability 2Mesothelioma, Malignant 2Mesothelioma 2Lymphoma 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Squamous Cell 2

Interventions

pembrolizumab 1motexafin gadolinium 1atezolizumab 1Semaxinib 1Ritonavir 1Radiotherapy 1Oxaliplatin 1Irinotecan 1Indinavir 1Immunoglobulin G 1Doxorubicin 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × atezolizumab × Dermatologic × Clear all
NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
133 enrolled
DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡